近期论文

查看导师新发文章 （温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

S Krishna, SW Seto, Roby Jose, E Biros, C Moran, Y Wang, P Clancy, J Golledge. A peptide antagonist of thrombospondin-1 promotes abdominal aortic aneurysm progression in the angiotensin II-infused apolipoprotein-E deficient mouse. Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB) 2015;35:389-98 (impact factor: 5.533) Y Wang. Letter bY Wang Regarding Article, "Efficacy and safety of catheter-based radiofrequency renal denervation in stented renal arteries" Circulation: Cardiovascular Interventions. 2015;8:e002117 (impact factor: 6.982). Y Wang. Is isolated systolic hypertension an indication for renal denervation? Frontiers in Physiology 2014;5:505. Y Wang. Ethnicity and sympathetic tone: predictors of the blood-pressure response to renal denervation? Nature Reviews Cardiology 2014; 11:638 (impact factor: 10.154). Y Wang. Letter bY Wang Regarding Article, "Renal Denervation for the Treatment of Cardiovascular High Risk-Hypertension or Beyond?" Circulation Research 2014; 115: e18 (impact factor: 11.089). Y Wang. Could pathophysiology failure be ruled out? American Journal of Medicine 2014; 127:e29 (impact factor: 5.302). Y Wang. What is the true incidence of renal artery stenosis after sympathetic denervation? Frontiers in Integrative Physiology 2014; 5:311. Y Wang. Ambulatory blood pressure may be designed as the primary efficacy outcome in clinical trials on renal denervation. International Journal of Cardiology 2014;176:1262-1263 (impact factor: 6.175). Y Wang. Single-sided renal denervation may be not suitable for patients with significant renal artery stenosis. Clinical Research in Cardiology 2014; 2014;103:950-951 (impact factor: 3.667). Y Wang, TI Emeto, J Lee, L Marshman, C Moran, S Seto, and J Golledge. Mouse models of intracranial aneurysm. Brain Pathology 2014; Doi: 10.1111/bpa.12175 (impact factor: 4.739). Y Wang, SM Krishna, J Moxon, TN Dinh, RJ Jose, H Yu, J Golledge. Influence of apolipoprotein E, age and aortic site on calcium phosphate induced abdominal aortic aneurysm in mice. Atherosclerosis 2014;235:204-12 (impact factor: 3.794). Y Wang. Renal denervation for resistant hypertension-the Symplicity HTN-1 study. Lancet 2014; 383:1885 (impact factor: 39.060). Y Wang. Renal denervation: the Irish experience. Hellenic Journal of Cardiology 2014;55:516 (impact factor: 1.227). Y Wang. It may be not suitable to perform renal denervation in renal arteries with significant stenosis. International Journal of Cardiology 2014;174:750 (impact factor: 6.175). Y Wang. Patients with renal artery stenosis may not be suitable for renal denervation. Clinical Research in Cardiology 2014;103:585-586 (impact factor: 3.667). Y Wang. Limitations in current clinical trials on renal denervation. International Journal of Cardiology 2014; 174:225 (impact factor: 6.175). Y Wang. Renal artery stenosis may be responsible for the gradual return of high blood pressure after renal denervation. Journal of Clinical Hypertension 2014; 16:313 (impact factor: 2.364). E Biros, CS Moran, Y Wang, PJ Walker, J Cardinal, J Golledge. MicroRNA profiling in patients with abdominal aortic aneurysms: the significance of miR-155. Clinical Science 2014;126:795-803 (impact factor: 4.859). Y Wang. More research is needed to investigate the effect of denervation on blood pressure. Hypertension 2014;63:e85 (impact factor: 7.632). Y Wang. It is urgent to investigate predictors of the response of blood pressure to renal denervation. Canadian Journal of Cardiology 2014;30:465.e7 (impact factor: 3.122).